Autoimmune myasthenia gravis

G. Lopate; A. Pestronk

doi:10.1080/21548331.1993.11442741

Autoimmune myasthenia gravis

G. Lopate
, A. Pestronk

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

The evident defect in this disease is postsynaptic dysfunction due to antiacetylcholine receptor antibodies. The postsynaptic membrane is simplified, the number of acetylcholine receptors is reduced, and neuromuscular transmission is impaired. Antiacetylcholinesterase drugs still play a role in management. Newer options include prednisone, azathioprine, and cyclosporine.

Original language	English
Pages (from-to)	109-112+115+117+121-122+127-128+131
Journal	Hospital Practice
Volume	28
Issue number	1
DOIs	https://doi.org/10.1080/21548331.1993.11442741
State	Published - 1993

Access to Document

10.1080/21548331.1993.11442741

Cite this

@article{f43b5295333544a69767056038108e73,

title = "Autoimmune myasthenia gravis",

abstract = "The evident defect in this disease is postsynaptic dysfunction due to antiacetylcholine receptor antibodies. The postsynaptic membrane is simplified, the number of acetylcholine receptors is reduced, and neuromuscular transmission is impaired. Antiacetylcholinesterase drugs still play a role in management. Newer options include prednisone, azathioprine, and cyclosporine.",

author = "G. Lopate and A. Pestronk",

year = "1993",

doi = "10.1080/21548331.1993.11442741",

language = "English",

volume = "28",

pages = "109--112+115+117+121--122+127--128+131",

journal = "Hospital Practice",

issn = "8750-2836",

number = "1",

}

TY - JOUR

T1 - Autoimmune myasthenia gravis

AU - Lopate, G.

AU - Pestronk, A.

PY - 1993

Y1 - 1993

N2 - The evident defect in this disease is postsynaptic dysfunction due to antiacetylcholine receptor antibodies. The postsynaptic membrane is simplified, the number of acetylcholine receptors is reduced, and neuromuscular transmission is impaired. Antiacetylcholinesterase drugs still play a role in management. Newer options include prednisone, azathioprine, and cyclosporine.

AB - The evident defect in this disease is postsynaptic dysfunction due to antiacetylcholine receptor antibodies. The postsynaptic membrane is simplified, the number of acetylcholine receptors is reduced, and neuromuscular transmission is impaired. Antiacetylcholinesterase drugs still play a role in management. Newer options include prednisone, azathioprine, and cyclosporine.

UR - https://www.scopus.com/pages/publications/0027399987

U2 - 10.1080/21548331.1993.11442741

DO - 10.1080/21548331.1993.11442741

M3 - Article

C2 - 8380423

AN - SCOPUS:0027399987

SN - 8750-2836

VL - 28

SP - 109-112+115+117+121-122+127-128+131

JO - Hospital Practice

JF - Hospital Practice

IS - 1

ER -

Autoimmune myasthenia gravis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this